Daily ShareChat: Nuplex Industries
By Jenny Ruth
Resins company Nuplex's profit upgrade just before Christmas, its second in just over a month, reflects management's increasing confidence in the sustainability of the market upturn and the ability of the restructured business to benefit from the recovery, says Dennis Lee, an analyst at Craigs Investment Partners.
"Overall demand conditions are still far from normal but Nuplex management notes demand has recovered from the low point and said it is seeing promising signs that the gradual recovery will continue into the foreseeable future," Lee says.
"Asia remains the standout region in terms of volume growth and profitability and all other regions except the US are showing signs of improvement," he says. Nevertheless, the US is still profitable.
The major risk to Nuplex is rising raw materials costs but the company has been able so far to contain those through product pricing, he says.
Lee has raising his forecast earnings before interest, tax, depreciation and amortisation in the year ending June by 9% to $115 million. He has also raised his target price by 9% to $3.28.
"We believe Nuplex's earnings are highly leveraged to the rebound in global economic activity now underway." The latest leading indicators support a continuation of the recovery, Lee says.
BROKER CALL: Craigs Investment Partners rate Nuplex as buy (when the share price was $2.79).
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
Nuplex enters Russian joint venture Nuplex shares plunge 7.8% after profit warning Nuplex gains regulatory approval for Viverso purchase Nuplex may replace some bank debt with first issue of bonds in US private placement market Nuplex to buy Bayer MaterialScience's Viverso, forecasts 10% earnings growth Nuplex bows to shareholder pressure, withdraws director fee hike proposal Nuplex directors ask for shareholders for 33% pay rise Nuplex pays A$23.5 mln for Acquo Masterbatch Nuplex full year profit up 7.5 pct Daily ShareChat: Nuplex
NZX Annoucements for NPX
|
|
Nuplex Industries Limited Ordinary Shares
Current quote:
NPX $2.61 +1
Quotes delayed 20 minutes
Price when article published: $3.13
Previous News
FREE Email News
Stock Quote
Today's Market Numbers
| NZX 50 Index |
3326.74 |
 |
2.10 |
| S&P/ASX 200 |
4282.90 |
 |
7.80 |
| Dow Jones Industrials |
12884.00 |
 |
5.80 |
Most Commented On
|
|


NZX 15 Index
|